• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血管扩张剂对缺血性心脏病和充血性心力衰竭患者综合治疗效果的影响]

[Effect of vasodilator agents on the effectiveness of the complex treatment of patients with ischemic heart disease and congestive heart failure].

作者信息

Nemirovskaia M A, Zharov E I, Vertkin A L

出版信息

Kardiologiia. 1989 Apr;29(4):37-40.

PMID:2666705
Abstract

A total of 153 coronary patients with congestive heart failure, stage IIA and IIB, were investigated. Thirty patients underwent a three-week course of treatment with cardiac glycosides, plus diuretics and potassium preparations where necessary. In addition to conventional treatment, 123 patients were treated with vasodilating agents (2% nitroglycerin ointment, nitrosorbide or molsidomin) with the doses adjusted individually on the basis of acute drug testing. Those patients with congestive heart failure who received combined treatment with cardiac glycosides and vasodilators demonstrated a more obvious improvement of clinical parameters and instrumental findings as compared to the patients, treated with cardiac glycosides alone.

摘要

共对153例IIA期和IIB期充血性心力衰竭的冠心病患者进行了研究。30例患者接受了为期三周的强心苷治疗疗程,必要时加用利尿剂和钾制剂。除常规治疗外,123例患者接受了血管扩张剂治疗(2%硝酸甘油软膏、硝异山梨酯或吗多明),剂量根据急性药物试验单独调整。与仅接受强心苷治疗的患者相比,接受强心苷和血管扩张剂联合治疗的充血性心力衰竭患者临床参数和器械检查结果改善更明显。

相似文献

1
[Effect of vasodilator agents on the effectiveness of the complex treatment of patients with ischemic heart disease and congestive heart failure].[血管扩张剂对缺血性心脏病和充血性心力衰竭患者综合治疗效果的影响]
Kardiologiia. 1989 Apr;29(4):37-40.
2
[Effect of molsidomine preparations on the contractile function of the myocardium and coronary circulation in patients with ischemic heart disease complicated by heart failure after isometric load].
Kardiologiia. 1989 Apr;29(4):44-7.
3
[Dilatation (congestive) cardiomyopathy: clinical aspects, diagnosis and treatment].[扩张型(充血性)心肌病:临床特点、诊断与治疗]
Kardiologiia. 1984 Nov;24(11):68-70.
4
[Chronopharmacodynamics of delayed-action cardiac glycosides and nitrates].[迟效强心苷和硝酸盐的时辰药效学]
Kardiologiia. 1990 Dec;30(12):11-3.
5
[Effect of the optimal dose of finoptin on various components of the circulatory system in heart failure in patients with ischemic heart disease].[缺血性心脏病心力衰竭患者中芬诺普汀最佳剂量对循环系统各组分的影响]
Kardiologiia. 1990 Jul;30(7):72-4.
6
[Use of peripheral vasodilator agents corbaton and corinfar combined with digoxin in patients with congestive heart failure of rheumatic etiology].[外周血管扩张剂可保通和冠心宁与地高辛联合用于风湿性病因的充血性心力衰竭患者]
Kardiologiia. 1990 Dec;30(12):60-1.
7
[Role of vasodilator agents in the complex treatment of circulatory insufficiency in patients with ischemic heart disease].[血管扩张剂在缺血性心脏病患者循环功能不全综合治疗中的作用]
Ter Arkh. 1986;58(5):127-31.
8
[Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].[洋地黄、利尿剂及血管扩张剂治疗扩张型心肌病]
Herz. 1985 Jun;10(3):138-42.
9
Indications for acute and chronic digitalis administration in heart failure.心力衰竭时急性和慢性洋地黄给药的适应证。
Henry Ford Hosp Med J. 1986;34(3):178-83.
10
[Use of mindronate in cardiac insufficiency in patients with ischemic heart disease].[米诺膦酸盐在缺血性心脏病患者心功能不全中的应用]
Klin Med (Mosk). 1990 Jan;68(1):39-42.